According to a French research, men
who begin losing their hair by the age of 20years double their chances of
prostate cancer later in life. However, no difference in the risk level was
seen among those who lost their hair later in life i.e. by the age of 30 or
A chemical called Di-Hydro-testosterone (DHT) which is produced by the male hormone testosterone is linked with male pattern baldness (androgenic alopecia). Testosterone is also linked with growth of cancer tumor. Researchers suggest that as a preventive anti-cancer treatment, an anti-baldness pill, finasteride which is popularly makerted as Propecia, could be given to individuals at a higher risk of prostate cancer. Finasteride prevents the conversion of testosterone to DHT, which promotes baldness.
These findings have been published in the journal Annals of Oncology.